Artelon is a biomaterial developed and sold by the Swedish company Artimplant. Artelon is a porous polyurethaneurea and acts as a scaffold which promotes ingrowth of native human tissue. Artelon degrades over a period of around 5–7 years during which time most of the material is replaced by native human tissue. Artelon's intended use includes resurfacing of joint surfaces (e.g. osteoarthritis, Hallux rigidus) and reinforcement and augmentation of tissue repair ( e.g. ligaments, tendons, general soft tissues).
- Nilsson A et al. (2010) ”The Artelon CMC spacer compared with tendon interposition arthroplasty.” Acta Orthop. 2010; 81 (2): 239–246
- Badia A. (2008) ”Arthroscopic indications and technique for artelon interposition arthroplasty of the thumb trapeziometacarpal joint.” Tech Hand Up Extrem Surg. 2008 Dec;12(4):236-41.
- Nilsson A. et al. (2005). ”Results from a degradable TMC joint spacer (Artelon) compared with tendon arthroplasty” J Hand Surg [Am] 30A:380-389. Abstract at PubMed
- Liljensten E, et al. (2002). "Studies of polyurethane urea bands for ACL reconstruction" J Mat Sci: Mat in Medicine 13(4): 351-359. Abstract at PubMed